Nurofen For Children 3 Months To 9 Years Orange (Ibuprofen)

Ibuprofen, the active ingredient in Nurofen For Children 3 Months To 9 Years Orange, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral suspension for oral use. It reduces fever and relieves mild to moderate pain in infants and children from three months up to nine years of age.

GNH USA supplies Nurofen For Children 3 Months To 9 Years Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that alleviates inflammation‑related symptoms in pediatric patients.

Fever: lowers elevated body temperature in children. Pain from teething: eases discomfort associated with teething. Mild to moderate pain: provides relief from headache, toothache, or minor injuries.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Stomach upset or dyspepsia - Nausea or vomiting - Diarrhoea - Mild skin rash - Headache - Dizziness

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Anaphylactic or severe allergic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Acute kidney injury or reduced renal function - Elevated liver enzymes or hepatitis - Blood clotting abnormalities such as thrombocytopenia

Before using this pediatric ibuprofen suspension, consider the following safety measures.

Age restriction: not for infants younger than three months without medical advice. Existing medical conditions: avoid in children with known hypersensitivity to NSAIDs, asthma, or renal/hepatic impairment. Concurrent NSAID use: do not combine with other NSAIDs or aspirin. Dehydration risk: ensure adequate fluid intake; avoid in severely dehydrated children. Dosage supervision: dosing must be determined by a qualified healthcare professional. Store at ambient temperature: keep in the original container, protect from moisture and direct heat.

Ibuprofen may interact with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: synergistic ulcer risk. - ACE inhibitors or ARBs in volume‑depleted patients: possible renal impairment. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance of ibuprofen. - Antihypertensives: potential attenuation of blood‑pressure‑lowering effect. - Methotrexate: reduced clearance leading to toxicity. - SSRIs: modest increase in bleeding tendency. - Oral hypoglycemics: possible alteration of glucose control.